Creso Pharma Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CPH.AX research report →
Price Chart
About the company
Creso Pharma Ltd. specializes in the development, registration, and commercialization of high-quality, pharmaceutical-grade cannabis and hemp-derived nutraceuticals. These health solutions are designed for both human and animal wellness, distributed across Europe, the Middle East, North America, and the Asia Pacific.
- CEO
- William Lay
- IPO
- 2016
- HQ
- Nedlands, WA, AU
Get TickerSpark's AI analysis on CPH.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $23.11M
- P/E
- -0.40
- PEG
- -0.00
- P/S
- 2.66
- P/B
- 0.59
- EV/EBITDA
- -0.94
- Div Yield
- 0.00%
- Gross Margin
- 3.30%
- Op Margin
- -225.19%
- Net Margin
- -377.28%
- ROE
- -130.99%
- ROIC
- -67.55%
Latest fiscal year · YoY change
- Revenue
- $8.69M+39.7%
- Gross Profit
- $287.00K+171.6%
- Op Income
- $-19,567,000
- Net Income
- $-32,782,000-3.2%
- EPS
- $-0.02+22.0%
- OCF Growth
- -37.8%
- FCF Growth
- -36.6%
- 52W High
- $0.05
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 2.62
- RSI (14)
- 40
- Avg Volume
- 10.01M
No earnings-call transcripts are available for CPH.AX yet.
- Free Float
- 58.9%
- Shares Outstanding
- 2.57B
- Float Shares
- 1.51B
Our CPH.AX coverage
Recent articles, reports, and earnings notes.
No research on CPH.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CPH.AX report →